Device Trial Radar · NCT02566447
"Solana™ Trichomonas Assay Field Study"
Last checked: Nov 19, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
750
Actual
Start
Oct 15, 2015
Primary completion
Aug 15, 2016
Study completion Aug 15, 2016
Sponsor
- Lead sponsor
- Quidel CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 2, 2015
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Solana® Trichomonas Assay is an in vitro qualitative nucleic acid amplification test for the detection of Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Helicase-Dependent Amplification (HDA) technology and the Solana instrument.
Conditions
- Trichomonas Vaginalis
Interventions
Solana Trichomonas Assay TestingDevice
Specimen collection of urine and/or vaginal swabs for testing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Trichomonas Test ResultTime frame: 2 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Johns Hopkins University School of Medicine
Baltimore, Maryland
University of North Carolina, Div. of Infectious Diseases
Chapel Hill, North Carolina
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.